Fig. 7From: Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapyDrug sensitivity analysis of WDHD1. The association between WDHD1 expression and drug sensitivity of rapamycin (A) and paclitaxel (B) in ten cancers. The horizontal coordinate indicates the high and low WDHD1 expression groups, and the vertical coordinate indicates the distribution of the IC50 score. *p < 0.05, **p < 0.01, ****p < 0.0001, ns, not statistically significantBack to article page